ConductScience.org, home

Paper16161069

Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).

Bernier J and 10 others. Head Neck, 2005. Cited by 1,334 papers, by iCite.

Cite this record

ConductScience Library. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Papers, record 16161069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16161069

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
PubMed
Journal
Head Neck
PubMed
Year
2005
PubMed
Publication types
Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,334
iCite
Relative citation ratio, by iCite
36.6
iCite
Revised in PubMed
2022-04-08
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bernier JJacques
2Cooper JSJay S
3Pajak TFT F
4van Glabbeke MM
5Bourhis JJ
6Forastiere AArlene
7Ozsahin EMEsat Mahmut
8Jacobs JRJohn R
9Jassem JJ
10Ang KKKie-Kian
11Lefèbvre JLJ L

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Head and Neck NeoplasmsMajor topic
Randomized Controlled Trials as TopicMajor topic
Antineoplastic Agents
Cisplatin
Combined Modality Therapy
Humans
Neoplasm Recurrence, Local
Neoplasm Staging
Prognosis
Risk
Survival Analysis

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
5U10 CA11488NCI NIH HHSUnited StatesU10CA011488PubMed and NIHNIH RePORTER
5U10 CA11488-33NCI NIH HHSUnited StatesU10CA114883PubMedNIH RePORTER

Download CSV of grants

Trials5

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00002555High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck CancerResultsClinicalTrials.gov
NCT00002670Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During SurgeryBackgroundClinicalTrials.gov
NCT03532737Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck CancerBackgroundClinicalTrials.gov
NCT05590650A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer PatientsBackgroundClinicalTrials.gov
NCT064924602 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell CarcinomaResultsClinicalTrials.gov

Download CSV of trials

Cited by575

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,334 citations.

PMIDTitleJournalYearIn PapersSource
42935733Beyond binary: a novel anatomical-geographical-biological framework for perineural invasion risk stratification in oral squamous cell carcinoma - a proof-of-concept study.Front Oncol2026https://conductscience.org/library/papers/42935733PubMed
42926249Real-world surgical outcomes and prognostic factors in stage III-IVA laryngeal squamous cell carcinoma: a multicenter, retrospective, cohort study in northern Japan.Int J Clin Oncol2026https://conductscience.org/library/papers/42926249PubMed
42848197[Combination of radiotherapy and medicinal anticancer therapy with curative intent].Radiologie (Heidelb)2026https://conductscience.org/library/papers/42848197PubMed
42828556Boesenbergia rotunda extract-based mucoadhesive mouth gargle for chemoradiation-induced oral mucositis: A prospective randomized controlled study.Support Care Cancer2026https://conductscience.org/library/papers/42828556PubMed
42807568The efficacy of concurrent chemoradiotherapy with or without nimotuzumab in high-risk patients with locally advanced head and neck squamous cell carcinoma post-surgery: A real-world study.Precis Radiat Oncol2026https://conductscience.org/library/papers/42807568PubMed
42802279Weight loss despite nutritional support predicts poor outcomes after postoperative chemoradiotherapy for high-risk head and neck cancer.Support Care Cancer2026https://conductscience.org/library/papers/42802279PubMed
42795862Radiotherapy in Squamous Cell Carcinoma of the Lip: A Systematic Review of Reported Practices, Clinical Outcomes, and Gaps in Consensus.J Clin Med2026https://conductscience.org/library/papers/42795862PubMed
42752870Immune checkpoint inhibitors in resectable and locoregionally advanced HNSCC: past lessons, present evidence, and future directions.Oncologist2026https://conductscience.org/library/papers/42752870PubMed
42709195Neoadjuvant combined immunotherapy with intratumoral TransCon TLR7/8 Agonist and systemic TransCon IL-2 β/y or pembrolizumab in patients with locally advanced oral cancer-a monocentric experience.Cancer Immunol Immunother2026https://conductscience.org/library/papers/42709195PubMed
42681211Clinical outcomes of near-infrared photoimmunotherapy according to immune checkpoint inhibitor timing and treatment sequence: a multicenter retrospective study.Int J Clin Oncol2026https://conductscience.org/library/papers/42681211PubMed
42658511Imaging-Detected Extranodal Extension in p16-Positive Oropharyngeal Cancer: Secondary Analysis of RTOG 1016.JAMA Otolaryngol Head Neck Surg2026https://conductscience.org/library/papers/42658511PubMed
42618776Influence of resection status on overall survival in p16-positive oropharyngeal carcinoma - a retrospective analysis of cancer registry data.Eur Arch Otorhinolaryngol2026https://conductscience.org/library/papers/42618776PubMed
42598158Variable-interval temporal feathering to optimize organs-at-risk repair for head and neck adaptive radiotherapy.Phys Imaging Radiat Oncol2026https://conductscience.org/library/papers/42598158PubMed
42361282Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer.J Clin Oncol2026https://conductscience.org/library/papers/42361282PubMed
42303822
Event-free survival and recurrence patterns after curative resection for locally advanced head and neck squamous cell carcinoma: single-institution real-world outcomes prior to the introduction of perioperative immunotherapy.
Int J Clin Oncol2026https://conductscience.org/library/papers/42303822PubMed
42279427Basic and Clinical Evidence for Perioperative Immunotherapy in Resectable HNSCC.Cancers (Basel)2026https://conductscience.org/library/papers/42279427PubMed
42237748YAP-activated lymph node fibroblasts contribute to extracellular matrix remodeling associated with extranodal extension of oral squamous cell carcinoma.J Pathol Clin Res2026https://conductscience.org/library/papers/42237748PubMed
42221217
Development of a Prognostic Nomogram Model and Establishment of a Risk Stratification System Based on the Naples Prognostic Score for Patients with Oropharyngeal Squamous Cell Carcinoma Who Have Undergone Radical Surgery.
J Inflamm Res2026https://conductscience.org/library/papers/42221217PubMed
42213481Cancer vaccines: comprehensive review.BJS Open2026https://conductscience.org/library/papers/42213481PubMed
42179829Commencement of Hypofractionated Adjuvant Radiation Therapy in Intermediate-Risk Oral Cavity Cancer: A Phase 1 Study Protocol (CHARIOT-1).Adv Radiat Oncol2026https://conductscience.org/library/papers/42179829PubMed

See all 575 cited byDownload CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
CISPLATINCHEMBL11359Results2https://conductscience.org/library/drugs/CHEMBL11359

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16161069

GET https://conductscience.org/api/papers/v1/16161069/cited_by?page=2